Defining, identifying and addressing problematic polypharmacy within multimorbidity in primary care: a scoping review
Introduction Polypharmacy and multimorbidity pose escalating challenges. Despite
numerous attempts, interventions have yet to show consistent improvements in health …
numerous attempts, interventions have yet to show consistent improvements in health …
Frequency and impact of medication reviews for people aged 65 years or above in UK primary care: an observational study using electronic health records
RM Joseph, RD Knaggs, CAC Coupland, A Taylor… - BMC geriatrics, 2023 - Springer
Background Medication reviews in primary care provide an opportunity to review and
discuss the safety and appropriateness of a person's medicines. However, there is limited …
discuss the safety and appropriateness of a person's medicines. However, there is limited …
Development of prescribing indicators related to opioid-related harm in patients with chronic pain in primary care—a modified e-Delphi study
Background Long-term opioid use is associated with dependency, addiction, and serious
adverse events. Although a framework to reduce inappropriate opioid prescribing exists …
adverse events. Although a framework to reduce inappropriate opioid prescribing exists …
A Pharmacist Perspective on Optimizing Pharmacotherapy among Older Adults–A Review
P Manirajan, P Sivanandy - F1000Research, 2024 - f1000research.com
Multimorbidity and the associated consumption of multiple medications are common among
the older population, posing a significant health concern. This leads to an increased …
the older population, posing a significant health concern. This leads to an increased …
[HTML][HTML] Pharmacist-led deprescribing using STOPPFrail for frail older adults in nursing homes
Objectives To evaluate the impact of pharmacist-guided deprescribing using the STOPPFrail
(Screening Tool of Older Persons' Prescriptions in Frail adults with a limited life expectancy) …
(Screening Tool of Older Persons' Prescriptions in Frail adults with a limited life expectancy) …
[HTML][HTML] The therapeutic landscape for COVID-19 and post-COVID-19 medications from genetic profiling of the Vietnamese population and a predictive model of drug …
Despite the raised awareness of the role of pharmacogenomic (PGx) in personalized
medicines for COVID-19, data for COVID-19 drugs is extremely scarce and not even a …
medicines for COVID-19, data for COVID-19 drugs is extremely scarce and not even a …
[HTML][HTML] Patients' Identification, Management and Prevention of Adverse Drug Reactions: A Cross-Sectional Survey of Patients with Severe Adverse Drug Reactions
W Srisuriyachanchai, AR Cox… - Journal of Clinical …, 2024 - mdpi.com
Background: Few studies have been conducted on how patients identify, manage, and
prevent severe adverse drug reactions (ADRs). This study aimed to explore the reasoning …
prevent severe adverse drug reactions (ADRs). This study aimed to explore the reasoning …
Коморбидность пациентов с хроническими неинфекционными заболеваниями в практике врача-терапевта. Евразийское руководство
ОМ Драпкина, АВ Концевая… - …, 2024 - cardiovascular.elpub.ru
Термин" коморбидность"(от лат. со—" вместе" и morbus—" болезнь") впервые дан в
1970 г. американским эпидемиологом Feinstein AR, утверждавшим, что" коморбидность …
1970 г. американским эпидемиологом Feinstein AR, утверждавшим, что" коморбидность …
Adverse Drug Reactions in Multimorbid Older People Exposed to Polypharmacy: Epidemiology and Prevention
S McGettigan, D Curtin, D O'Mahony - Pharmacoepidemiology, 2024 - mdpi.com
Adverse drug reactions (ADRs) are frequent and represent a significant healthcare burden.
ADRs are a potentially avoidable contributor to excess unscheduled hospital admissions …
ADRs are a potentially avoidable contributor to excess unscheduled hospital admissions …
[HTML][HTML] Intervención farmacéutica en la revisión del tratamiento en pacientes mayores polimedicados institucionalizados
CP Bolaños, IS García, IG Valbuena, LV Ruíz… - Atencion Primaria, 2024 - Elsevier
Objetivo Describir los problemas relacionados con la medicación (PRM) detectados y su
resolución tras la intervención farmacéutica en la revisión del tratamiento de pacientes …
resolución tras la intervención farmacéutica en la revisión del tratamiento de pacientes …